Zusammenfassung
Dieses Kapitel beschreibt die Grundlagen der renoparenchymatösen Tumoren, wobei der Schwerpunkt naturgemäß auf dem Nierenzellkarzinom liegt. Auf eine Übersicht über epidemiologische Daten folgt eine Darstellung der Ätiologie und Risikofaktoren, wobei in dieser Hinsicht zwar einige etablierte Parameter definiert werden konnten, aber letztlich noch vieles im Dunkeln liegt. Die Übersicht über die verschiedenen histologischen Subtypen der renalen Neoplasien schließt auch eine eingehende Beschreibung hereditärer Krankheitsbilder ein. Abschließend wird noch auf die klinische Symptomatik und die Diagnostik eingegangen, wobei das Hauptaugenmerk in der Diagnostik renaler Raumforderungen auf der Bildgebung liegt.
Das folgende Kapitel beschreibt die Grundlagen der renoparenchymatösen Tumoren, wobei der Schwerpunkt naturgemäß auf dem Nierenzellkarzinom liegt. Auf eine Übersicht über epidemiologische Daten folgt eine Darstellung der Ätiologie und Risikofaktoren, wobei in dieser Hinsicht zwar einige etablierte Parameter definiert werden konnten, aber letztlich noch vieles im Dunkeln liegt. Die Übersicht über die verschiedenen histologischen Subtypen der renalen Neoplasien schließt auch eine eingehende Beschreibung hereditärer Krankheitsbilder ein. Abschließend wird noch auf die klinische Symptomatik und die Diagnostik eingegangen, wobei das Hauptaugenmerk in der Diagnostik renaler Raumforderungen auf der Bildgebung liegt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Argani P, Lae M, Ballard ET, Amin M, Manivel C, Hutchinson B et al (2006) Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24(10):1529–1534
Ascenti G, Mazziotti S, Zimbaro G et al (2007) Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243:158–165
Banumathy G, Cairns P (2010) Signaling pathways in renal cell carcinoma. Cancer Biol Ther 10:658–664
Bedke J, Buse S, Kurosch M, Haferkamp A, Jager D, Hohenfellner M (2007) Paraneoplastic syndrome in renal cell carcinoma. Urologe A 46(1):45–48
Bellocco R, Pasquali E, Rota M, Bagnardi V, Tramacere I, Scotti L et al (2012) Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncol 23(9):2235–2244
Birt AR, Hogg GR, Dubé WJ (1977) Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113(12):1674
Bosniak MA (1997) The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol 157(5):1852–1853
Cindolo L, de la Taille A, Messina G et al (2003) A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int 92:901–905
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M et al (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284
Delahunt B, Eble JN, McCredie M, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32(6):590
Eble JN, Sauter G, Epstein JI (2004) Pathology and genetics of tumours of the urinary system and male genital organs, 7. Aufl, WHO classification of tumours. World Health Organisation, Lyon
Ferlay J, Parkin DM, Steliarova-Foucher E (2010a) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM (2010b) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655
Hallscheidt P, Noeldge G, Schawo S et al (2007) Advances in the staging of renal cell carcinoma with high-resolution imaging. Rofo 179:1236–1242
Hiddemann W, Bartram C (2010) Nierenzellkarzinom. In: Hiddemann W, Bartram C (Hrsg) Die Onkologie Teil 2: Solide Tumoren - Lymphome - Leukämien, 2. Aufl. Springer Medizin Verlag, Heidelberg, S 1088–1103
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114(1):101–108
Hutterer GC, Patard JJ, Perrotte P et al (2007) Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer 121:2556–2561
Hutterer GC, Patard JJ, Jeldres C et al (2008) Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram. BJU Int 101:39–43
Inoki K, Li Y, Zhu T, Wu J, Guan K (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648–657
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8(2):143–153
Israel G, Bosniak A (2005) How I do it: evaluating renal masses. Radiology 236:441–450
Kalinka A, Gerlach A, Arlart IP, Gunes N, Hauser TK, Wurstlin S, Bosse A (2006) Characterization and staging of renal tumors: significance of MRI diagnostics. Rofo 178:298–305
Karakiewicz PI, Suardi N, Capitanio U et al (2009) A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 55:287–295
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (Hrsg) Evaluation of chemotherapeutic agents. Columbia University Press, New York, S 191–205
Keaney JJ, Hannon CM, Murray PT (2013) Contrast-induced acute kidney injury: how much contrast is safe? Nephrol Dial Transplant 28:1376–1383
Klatte T (2012) The contemporary role of renal tumor biopsy. Eur Urol 62(3):505–506
Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18(3):935–942
Kutikov A, Egleston BL, Wong YN, Uzzo RG (2010) Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28:311–317
Latif F, Tory K, Gnarra J, Yao M, Duh F, Orcutt ML et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317
Linehan WM, Srinivasan R, Schmidt LS (2010) The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 7:277–285
Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176(6):2353–2358
Lipworth L, Tarone RE, McLaughlin JK (2011) Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer. 11:133
Ljungberg B, Campbell SC, Cho HY, Jacqmin D, Lee JE, Weikert S et al (2011) The epidemiology of renal cell carcinoma. Eur Urol 60(4):615–621
Ljungberg B, Bensalah K, Bex A et al (2015) EAU guidelines on renal cell carcinoma, update 2015. http://uroweb.org/guideline/renal-cell-carcinoma/. Zugegriffen im März 2015.
Maher ER, Neumann HP, Richard S (2011) von Hippel–Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617–623
McDonald JS, McDonald RJ, Comin J et al (2013) Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 267:119–128
Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S et al (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol 10(12):1199–1206
Moch H (2013) An overview of renal cell cancer: pathology and genetics. Semin Cancer Biol 23:3–9
Moch H, Artibani W, Delahunt B, Ficarra V, Knuechel R, Montorsi F et al (2009) Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 56(4):636–643
Navai N, Wood CG (2012) Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol 30(2):220–224
Nguyen CT, Campbell SC (2006) Staging of renal cell carcinoma: past, present, and future. Clin Genitourin Cancer 5(3):190–197
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–656
Pallwein L, Mitterberger M, Aigner F et al (2007) Small renal masses: the value of contrast-enhanced colour Doppler imaging. BJU Int 99:579–585
Patard J, Leray E, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B (2003) Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 44(2):226–232
Patard J, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23(12):2763–2771
Pichler M, Hutterer GC, Chromecki TF et al (2011) External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol 186:1773–1777
Protzel C, Maruschke M, Hakenberg OW (2012) Epidemiology, aetiology, and pathogenesis of renal cell carcinoma. Eur Urol Suppl 11(3):52–59
Raj GV, Thompson RH, Leibovich BC et al (2008) Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179:2146–2151
Remzi M, Marberger M (2009) Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol 55(2):359–367
Rioux-Leclercq N, Karakiewicz PI, Trinh Q, Ficarra V, Cindolo L, de la Taille A et al (2007) Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 109(5):868–874
Ross H, Argani P (2010) Xp11 translocation renal cell carcinoma. Pathology 42(4):369–373
Roth JS, Rabinowitz AD, Benson M, Grossman ME (1993) Bilateral renal cell carcinoma in the Birt-Hogg-Dube syndrome. J Am Acad Dermatol 29(6):1055–1056
Schaefer-Prokop CM (1998) Bildgebende Diagnostik des Nierenzellkarzinoms. Onkologe 4:221–228
Schips L, Lipsky K, Zigeuner R et al (2003) Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 62:1024–1028
Sobin L, Gospodarowicz M, Wittekind C (2009) AJCC staging manual, 7. Aufl. Springer, Philadelphia
Srigley JR, Delahunt B (2009) Uncommon and recently described renal carcinomas. Mod Pathol 22(Suppl 2):S2–S23
Studer UE, Scherz S, Scheidegger J et al (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144:243–245
Tran LN, Brown MS, Goldin JG et al (2004) Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol 11:1355–1360
Truong LD, Krishnan B, Cao JTH, Barrios R, Suki WN (1995) Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 26(1):1–12
Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N et al (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 58(5):701–710
Yaycioglu O, Roberts WW, Chan T et al (2001) Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model. Urology 58:141–145
Zhang J, Lefkowitz RA, Ishill NM et al (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244:494–504
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zigeuner, R., Golbeck, S.V., Pichler, M. (2016). Nierenparenchymtumoren. In: Michel, M., Thüroff, J., Janetschek, G., Wirth, M. (eds) Die Urologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39940-4_63
Download citation
DOI: https://doi.org/10.1007/978-3-642-39940-4_63
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39939-8
Online ISBN: 978-3-642-39940-4
eBook Packages: Medicine (German Language)